Tandem Diabetes Care (TNDM) Earnings Date, Estimates & Call Transcripts $35.15 -2.38 (-6.34%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Tandem Diabetes Care Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 26After Market ClosesEstimatedActual EPS (Nov. 6) -$0.35 Beat By $0.08 Consensus EPS (Nov. 6) -$0.43 Tandem Diabetes Care announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.35, which topped the consensus estimate of -$0.43 by $0.08. Quarterly revenue rose 31.4% year-over-year to $243.97 million, above analyst estimates of $224.14 million. With a trailing EPS of -$1.93, Tandem Diabetes Care's earnings are expected to grow next year, from ($1.68) to ($1.20) per share. Conference CallEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingPowered by TNDM Upcoming EarningsTandem Diabetes Care's next earnings date is estimated for Wednesday, February 26, 2025, based off prior year's reporting schedules. Get Tandem Diabetes Care Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tandem Diabetes Care and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTNDM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TNDM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Tandem Diabetes Care Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.66-$0.42-$0.54Q2 20252-$0.38-$0.37-$0.38Q3 20251-$0.08-$0.08-$0.08Q4 20251-$0.10-$0.10-$0.10FY 20256($1.22)($0.97)($1.10) Tandem Diabetes Care Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/26/2025(Estimated)-------11/6/2024Q3 2024-$0.43-$0.35+$0.08-$0.37$224.14M$243.97M8/1/2024Q2 2024-$0.54-$0.47+$0.07-$0.47$205.63M$221.90M5/2/2024Q1 2024-$0.80-$0.63+$0.17-$0.61$173.06M$191.67M2/21/2024Q4 2023-$0.23-$0.27 -$0.04-$0.08$204.86M$196.80M11/1/2023Q3 2023-$0.35-$0.38 -$0.03-$0.25$193.33M$185.62M8/3/2023Q2 2023-$0.54-$0.30+$0.24-$0.05$201.62M$195.92M5/3/2023Q1 2023-$0.56-$0.63 -$0.07$0.66$171.59M$169.38M2/22/2023Q4 2022-$0.0160-$0.01+$0.0060$0.23$221.99M$223.45M Tandem Diabetes Care Earnings - Frequently Asked Questions When is Tandem Diabetes Care's earnings date? Tandem Diabetes Care has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on TNDM's earnings history. What guidance has Tandem Diabetes Care issued on next quarter's earnings? Tandem Diabetes Care issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $903.0 million-$910.0 million, compared to the consensus revenue estimate of $891.0 million. Did Tandem Diabetes Care beat their earnings estimates last quarter? In the previous quarter, Tandem Diabetes Care (NASDAQ:TNDM) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.08. Learn more on analysts' earnings estimate vs. TNDM's actual earnings. How can I listen to Tandem Diabetes Care's earnings conference call? The conference call for Tandem Diabetes Care's latest earnings report can be listened to online. Listen to Conference Call How can I view Tandem Diabetes Care's earnings report? Tandem Diabetes Care's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Tandem Diabetes Care generate each year? Tandem Diabetes Care (NASDAQ:TNDM) has a recorded annual revenue of $747.72 million. How much profit does Tandem Diabetes Care generate each year? Tandem Diabetes Care (NASDAQ:TNDM) has a recorded net income of -$222.61 million. TNDM has generated -$1.93 earnings per share over the last four quarters. What is Tandem Diabetes Care's EPS forecast for next year? Tandem Diabetes Care's earnings are expected to grow from ($1.68) per share to ($1.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies Glaukos Earnings Date Stevanato Group Earnings Date Bausch + Lomb Earnings Date Inspire Medical Systems Earnings Date Inari Medical Earnings Date PROCEPT BioRobotics Earnings Date Envista Earnings Date iRhythm Technologies Earnings Date NovoCure Earnings Date LivaNova Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:TNDM) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
